To report side effects, call 800-FDA-1088.
Physician Prescribing Information
View the physician Prescribing Information in PDF format
Important information about ZOLINZA
ZOLINZA is a medicine used to treat a type of cancer called cutaneous T-cell lymphoma, also called CTCL. ZOLINZA is used in patients when the CTCL gets worse, does not go away, or comes back after treatment with other medicines.
- A possible serious side effect is an abnormality on your electrocardiogram, or EKG. Your doctor will check your blood electrolytes and EKG.
- The most common side effects of ZOLINZA include stomach problems, such as diarrhea, nausea, vomiting, loss of appetite, constipation, and weight loss; tiredness; taste changes; muscle aches; and hair loss.
- Your doctor will tell you how many ZOLINZA capsules to take and when to take them. Swallow each capsule whole; do not chew it or break it open. If you cannot swallow the capsules whole, tell your doctor. You may need a different medicine.
- ZOLINZA is available by prescription only.
- Please read the Patient Information for ZOLINZA and discuss it with your doctor. The physician Prescribing Information also is included on this site.
- You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
ZOLINZA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
This site is intended for residents of the United States, its territories, and Puerto Rico.
20850619(7)-01/10-ZOL
This site is intended for residents of the United States, its territories, and Puerto Rico.
20850619(7)-01/10-ZOL